Source Natural Foods & Herbal Supplements Ltd
Incorporated in 1998, Source Natural Foods
and Herbal Supplements Ltd provides Ayurveda, Health & Dietary Supplements and Food Products[1]
- Market Cap ₹ 144 Cr.
- Current Price ₹ 223
- High / Low ₹ 270 / 78.0
- Stock P/E 56.3
- Book Value ₹ 32.2
- Dividend Yield 0.00 %
- ROCE 18.5 %
- ROE 9.52 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
- Company's working capital requirements have reduced from 145 days to 115 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 12.7% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3.76 | 4.54 | 6.54 | 10.93 | 15.94 | 10.84 | 12.81 | 13.59 | 24.88 | 21.53 | 19.79 | 27.30 | 33.25 | |
3.16 | 4.12 | 5.83 | 9.97 | 14.12 | 9.43 | 11.22 | 11.20 | 20.71 | 17.68 | 16.18 | 22.83 | 27.76 | |
Operating Profit | 0.60 | 0.42 | 0.71 | 0.96 | 1.82 | 1.41 | 1.59 | 2.39 | 4.17 | 3.85 | 3.61 | 4.47 | 5.49 |
OPM % | 15.96% | 9.25% | 10.86% | 8.78% | 11.42% | 13.01% | 12.41% | 17.59% | 16.76% | 17.88% | 18.24% | 16.37% | 16.51% |
0.00 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.02 | 0.33 | 0.49 | 0.01 | -0.04 | -0.04 | |
Interest | 0.00 | 0.00 | 0.01 | 0.01 | 0.07 | 0.24 | 0.20 | 0.23 | 0.10 | 0.24 | 0.27 | 0.21 | 0.36 |
Depreciation | 0.25 | 0.26 | 0.54 | 0.49 | 0.35 | 0.35 | 0.34 | 0.34 | 0.37 | 0.42 | 0.62 | 1.04 | 1.04 |
Profit before tax | 0.35 | 0.17 | 0.16 | 0.47 | 1.41 | 0.83 | 1.05 | 1.84 | 4.03 | 3.68 | 2.73 | 3.18 | 4.05 |
Tax % | 0.00% | 0.00% | 0.00% | 10.64% | 0.71% | 3.61% | 2.86% | 11.41% | 16.38% | 33.97% | 22.71% | 45.28% | |
0.35 | 0.17 | 0.16 | 0.43 | 1.40 | 0.80 | 1.03 | 1.64 | 3.37 | 2.43 | 2.12 | 1.74 | 2.54 | |
EPS in Rs | 0.78 | 0.33 | 0.26 | 0.67 | 2.17 | 1.24 | 1.60 | 2.55 | 5.24 | 3.78 | 3.29 | 2.70 | 3.94 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 62.52% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 20% |
5 Years: | 16% |
3 Years: | 3% |
TTM: | 36% |
Compounded Profit Growth | |
---|---|
10 Years: | 26% |
5 Years: | 11% |
3 Years: | -19% |
TTM: | 30% |
Stock Price CAGR | |
---|---|
10 Years: | 33% |
5 Years: | 30% |
3 Years: | 22% |
1 Year: | 147% |
Return on Equity | |
---|---|
10 Years: | 15% |
5 Years: | 16% |
3 Years: | 13% |
Last Year: | 10% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.50 | 5.20 | 6.10 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 |
Reserves | -2.09 | -0.15 | -0.96 | -0.88 | 0.53 | 1.33 | 2.36 | 3.35 | 6.73 | 9.16 | 11.28 | 13.02 | 14.28 |
2.22 | 0.00 | 0.09 | 0.08 | 1.91 | 1.77 | 0.16 | 1.12 | 0.93 | 0.04 | 0.02 | 0.00 | 6.30 | |
0.33 | 0.45 | 0.77 | 0.98 | 2.63 | 1.56 | 1.84 | 2.23 | 3.13 | 3.69 | 3.96 | 4.19 | 4.27 | |
Total Liabilities | 4.96 | 5.50 | 6.00 | 6.62 | 11.51 | 11.10 | 10.80 | 13.14 | 17.23 | 19.33 | 21.70 | 23.65 | 31.29 |
3.48 | 3.87 | 3.66 | 3.31 | 3.53 | 3.58 | 3.57 | 3.31 | 3.88 | 5.00 | 6.56 | 5.52 | 5.01 | |
CWIP | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.34 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
1.47 | 1.63 | 2.34 | 3.31 | 7.98 | 7.52 | 7.23 | 9.83 | 13.01 | 14.33 | 15.14 | 18.13 | 26.28 | |
Total Assets | 4.96 | 5.50 | 6.00 | 6.62 | 11.51 | 11.10 | 10.80 | 13.14 | 17.23 | 19.33 | 21.70 | 23.65 | 31.29 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.49 | 0.00 | 0.38 | 0.38 | -0.69 | 0.11 | 2.64 | -0.36 | 4.46 | -0.70 | 2.51 | 2.69 | |
-0.30 | 0.00 | -0.40 | -0.16 | -1.95 | 0.14 | -0.31 | -0.71 | -2.09 | 0.07 | 0.06 | 0.29 | |
0.19 | 0.00 | 0.11 | 0.01 | 2.06 | -0.42 | -1.60 | 0.32 | 0.32 | -1.20 | -0.53 | -0.04 | |
Net Cash Flow | 0.38 | 0.00 | 0.08 | 0.23 | -0.58 | -0.18 | 0.74 | -0.74 | 2.69 | -1.83 | 2.04 | 2.95 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 11.65 | 28.14 | 12.84 | 27.72 | 100.52 | 139.06 | 94.88 | 182.37 | 87.88 | 131.22 | 136.67 | 100.41 |
Inventory Days | 142.99 | 143.08 | 218.30 | 143.24 | 115.92 | 202.88 | 149.49 | 92.38 | 64.09 | 106.83 | 141.55 | 93.53 |
Days Payable | 101.60 | 90.52 | 108.28 | 81.70 | 84.18 | 36.13 | 46.29 | 58.58 | 22.10 | 57.67 | 78.93 | 60.91 |
Cash Conversion Cycle | 53.04 | 80.70 | 122.86 | 89.26 | 132.26 | 305.81 | 198.08 | 216.16 | 129.86 | 180.37 | 199.29 | 133.04 |
Working Capital Days | 46.60 | 58.69 | 58.60 | 53.76 | 111.74 | 178.80 | 114.54 | 183.17 | 82.01 | 163.43 | 157.14 | 114.71 |
ROCE % | 8.28% | 3.51% | 3.31% | 8.83% | 20.39% | 11.62% | 13.51% | 20.84% | 33.11% | 26.36% | 17.97% | 18.49% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
14 Nov - Newspaper publication of unaudited financial results for the quarter and half year ended September 30, 2024.
- Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024. 12 Nov
-
Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024
12 Nov - Board meeting outcome and unaudited financial results for Q2 2024.
-
Board Meeting Intimation for Consideration Of Un-Audited Financial Results Of The Company For The Quarter And Half Year Ended 30Th September 2024.
7 Nov - Board meeting to discuss business diversification and financial results.
-
Announcement Under Regulation 30 - Reconstitution Of Committees
28 Oct - Reconstitution of Board Committees effective October 1, 2024.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Product Profile:
a) Beverages:[1]
Ojasvita - Chocolate, Malt, Strawberry, Mango, Golden Latte, etc.
b) Supplements:[2]
Turmeric Plus, Amla, Yastimadhu, Triphala, Nishamlaki, Arjuna
c) Arkas:[3]
Shakti Drops, Tulsi Araka, Ajamoda Arka
d) Single Herbs:[4]
Shakhpushpi, Shatavari, Tulsi, Neem, Brahmi, Ashwagandha, Amrut, Kalamegh, Haritaki
e) Churnas:[5]
Sitophaladi, Hingvastaka, Triphala